Vasculogenic mimicry is associated with trastuzumab resistance of HER2-positive breast cancer

BACKGROUND: Trastuzumab is a drug that targets the receptor tyrosine kinase HER2 and is essential for the treatment of HER2-positive breast cancer. Resistance to the drug leads to severe consequences, including disease recurrence, tumor enlargement, and metastasis. We hypothesized that trastuzumab t...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Breast Cancer Res
Autori principali: Hori, Ami, Shimoda, Masafumi, Naoi, Yasuto, Kagara, Naofumi, Tanei, Tomonori, Miyake, Tomohiro, Shimazu, Kenzo, Kim, Seung Jin, Noguchi, Shinzaburo
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2019
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6683360/
https://ncbi.nlm.nih.gov/pubmed/31387614
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-019-1167-3
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi